BioLargo, Inc.
BLGO
$0.2365
$0.00351.50%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.78M | 18.50M | 16.82M | 13.25M | 12.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.78M | 18.50M | 16.82M | 13.25M | 12.23M |
| Cost of Revenue | 9.93M | 10.30M | 8.91M | 6.66M | 6.08M |
| Gross Profit | 7.86M | 8.19M | 7.91M | 6.59M | 6.15M |
| SG&A Expenses | 9.30M | 8.99M | 9.17M | 8.56M | 8.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -1.00K | -42.00K | 13.00K | 13.00K |
| Total Operating Expenses | 22.11M | 21.82M | 20.58M | 17.73M | 16.43M |
| Operating Income | -4.33M | -3.33M | -3.76M | -4.48M | -4.20M |
| Income Before Tax | -4.35M | -3.64M | -4.08M | -4.93M | -4.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.35 | -3.64 | -4.08 | -4.93 | -4.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.95M | 1.52M | 1.30M | 1.26M | 1.14M |
| Net Income | -2.40M | -2.12M | -2.78M | -3.67M | -3.50M |
| EBIT | -4.33M | -3.33M | -3.76M | -4.48M | -4.20M |
| EBITDA | -4.18M | -3.20M | -3.63M | -4.37M | -4.10M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.19B | 1.18B | 1.17B | 1.16B | 1.14B |
| Average Diluted Shares Outstanding | 1.19B | 1.18B | 1.17B | 1.16B | 1.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |